Raymond James & Associates Sol Gel Technologies Ltd. Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Sol Gel Technologies Ltd. stock. As of the latest transaction made, Raymond James & Associates holds 31,623 shares of SLGL stock, worth $265,949. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,623

Previous 33,631 5.97%

Holding current value

$265,949

Previous $29,000 27.59%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$0.37 - $0.96 $742 - $1,927	-2,008 Reduced 5.97%	31,623 $21,000
Q2 2024 Jul 19, 2024	BUY	$0.66 - $1.05 $1,751 - $2,786	2,654 Added 8.57%	33,631 $29,000
Q1 2024 Apr 22, 2024	BUY	$0.95 - $1.5 $58 - $93	62 Added 0.2%	30,977 $30,000
Q4 2023 Jan 16, 2024	SELL	$0.92 - $1.6 $4,182 - $7,273	-4,546 Reduced 12.82%	30,915 $34,000
Q3 2023 Oct 24, 2023	SELL	$1.63 - $3.94 $868 - $2,100	-533 Reduced 1.48%	35,461 $57,000
Q2 2023 Jul 25, 2023	SELL	$2.99 - $4.15 $1,758 - $2,440	-588 Reduced 1.61%	35,994 $107,000
Q1 2023 Apr 14, 2023	BUY	$3.44 - $5.32 $15,246 - $23,578	4,432 Added 13.79%	36,582 $141,000
Q4 2022 Feb 08, 2023	SELL	$4.26 - $5.22 $53,901 - $66,048	-12,653 Reduced 28.24%	32,150 $146,000
Q3 2022 Oct 25, 2022	SELL	$4.16 - $6.4 $11,552 - $17,772	-2,777 Reduced 5.84%	44,803 $225,000
Q2 2022 Aug 12, 2022	BUY	$4.1 - $7.36 $360 - $647	88 Added 0.19%	47,580 $195,000
Q1 2022 May 11, 2022	BUY	$6.64 - $8.21 $63,949 - $79,070	9,631 Added 25.44%	47,492 $350,000
Q4 2021 Feb 08, 2022	BUY	$6.57 - $9.78 $8,232 - $12,254	1,253 Added 3.42%	37,861 $281,000
Q3 2021 Nov 02, 2021	BUY	$8.85 - $12.5 $39,993 - $56,487	4,519 Added 14.08%	36,608 $365,000
Q2 2021 Aug 11, 2021	SELL	$9.53 - $14.7 $6,223 - $9,599	-653 Reduced 1.99%	32,089 $397,000
Q1 2021 May 14, 2021	SELL	$8.75 - $15.49 $14,166 - $25,078	-1,619 Reduced 4.71%	32,742 $405,000
Q4 2020 Feb 12, 2021	SELL	$7.11 - $9.99 $98,971 - $139,060	-13,920 Reduced 28.83%	34,361 $336,000
Q3 2020 Nov 04, 2020	BUY	$7.15 - $8.73 $46,324 - $56,561	6,479 Added 15.5%	48,281 $350,000
Q2 2020 Jul 28, 2020	BUY	$6.15 - $9.4 $1,328 - $2,030	216 Added 0.52%	41,802 $375,000
Q1 2020 Apr 21, 2020	BUY	$5.88 - $15.75 $38,696 - $103,650	6,581 Added 18.8%	41,586 $294,000
Q4 2019 Feb 12, 2020	SELL	$7.5 - $17.15 $45,382 - $103,774	-6,051 Reduced 14.74%	35,005 $600,000
Q3 2019 Nov 07, 2019	SELL	$7.7 - $10.48 $117,417 - $159,809	-15,249 Reduced 27.08%	41,056 $369,000
Q2 2019 Aug 06, 2019	BUY	$6.78 - $9.49 $103,361 - $144,675	15,245 Added 37.13%	56,305 $515,000
Q1 2019 May 06, 2019	BUY	$5.71 - $7.19 $105,064 - $132,296	18,400 Added 81.2%	41,060 $281,000
Q4 2018 Feb 11, 2019	SELL	$5.79 - $8.1 $12,159 - $17,010	-2,100 Reduced 8.48%	22,660 $136,000
Q3 2018 Nov 14, 2018	BUY	$6.2 - $7.8 $71,300 - $89,700	11,500 Added 86.73%	24,760 $186,000
Q2 2018 Aug 14, 2018	BUY	$7.5 - $10.71 $99,450 - $142,014	13,260 New	13,260 $102,000

Others Institutions Holding SLGL

# of Institutions

Shares Held

5.38M

Call Options Held

20.1K

Put Options Held

View Full List

About Sol-Gel Technologies Ltd.

Ticker SLGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,129,500
Market Cap $195M
Description
Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...

More about SLGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Sol Gel Technologies Ltd. Transaction History